Fox Chase Cancer Center Physician Receives Grant from Pennsylvania Department of Health's Tax-Refund Program
PHILADELPHIA (March 1, 2000) -- Mary Daly, M.D., Ph.D., Director of Fox Chase Cancer Center's Margaret Dyson Family Risk Assessment Program for breast and ovarian cancer, will receive a year 2000 cancer research grant from the Department of Health funded by state income tax refunds. More than 30,000 Pennsylvanians opted to donate their state income tax refund by filling in a donation line that indicated their refund be used for breast and cervical cancer research.
Pennsylvania's First Lady Michele Ridge was present for the announcement of the grant recipients at a ceremony held today at the Milton S. Hershey Medical Center. A total of $177,708 was awarded to six researchers at four institutions.
Daly will use her one year $30,000 grant to expand research programs that help counsel women when they receive results of cancer genetic testing. Daly currently directs programs that provide successful counseling and support strategies for individuals undergoing genetic testing. The specific aim of this new program will be to determine if individuals participating in a support group express more satisfaction with their decision to undergo genetic counseling and to receive genetic test results.
"Counseling for hereditary cancer risk is relatively new," said Daly. "Although the best method of delivering this information is yet to be determined, there is growing appreciation for the need of psychological intervention and long term education and support. As we provide women with such powerful information about their genetic make-up, we should help them understand it and use it to their benefit."
The Pennsylvania Breast Cancer Coalition spearheaded efforts to pass the Breast and Cervical Cancer Research Act, allowing taxpayers to donate their state tax refund or to make direct contributions to breast and cervical cancer research. The grants are awarded by the Pennsylvania Department of Health.
Fox Chase Cancer Center, one of the nation's first comprehensive cancer centers designated by the National Cancer Institute in 1974, conducts basic and clinical research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center's web site at: www.fccc.edu.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.